NCT07566585
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07566585
Title Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BlueSphere Bio, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University at St Louis RECRUITING St Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field